作者: Emilio Maseda , José Mensa , Juan-Carlos Valía , José-Ignacio Gomez-Herreras , Fernando Ramasco
DOI: 10.1016/J.REDAR.2013.11.012
关键词: Bacteremia 、 Medicine 、 Pseudomonas aeruginosa 、 Acinetobacter baumannii 、 Antibiotics 、 Methicillin-resistant Staphylococcus aureus 、 Pneumonia 、 Intensive care medicine 、 Disease reservoir 、 Multiple drug resistance
摘要: ICUs are areas where resistance problems the largest, and these constitute a major problem for intensivist's clinical practice. Main phenotypes among nosocomial microbiota (i) vancomycin-resistance/heteroresistance tolerance in grampositives (MRSA, enterococci) (ii) efflux pumps/enzymatic mechanisms (ESBLs, AmpC, metallo-betalactamases) gramnegatives. These found at different rates pathogens causing respiratory (nosocomial pneumonia/ventilator-associated pneumonia), bloodstream (primary bacteremia/catheter-associated bacteremia), urinary, intraabdominal surgical wound infections endocarditis ICU. New antibiotics available to overcome non-susceptibility grampositives; however, accumulation of traits gramnegatives has led multidrug resistance, worrisome nowadays. This article reviews microorganism/infection risk factors suggesting adequate empirical treatments. Drugs, patient environmental all play role decision prescribe/recommend antibiotic regimens specific ICU patient, implying that intensivists should be familiar with drugs, epidemiology factors.